Empower Gene Table by Panel

Signatera Altera Requisition Form

Form necessary to request Signatera tests for use with patients.

Prospera Sample Collection Instructions

A step by step breakdown of how to properly collect a patient's blood for the Prospera test.

Indications For Use GenNeph

Prospera™ is a donor-derived cell-free DNA (dd-cfDNA) test for assessment of rejection in post-renal-transplant patients.

Signatera Testing for Circulating Tumor DNA ctDNA Detection

Detect residual disease and recurrence early in colorectal cancer (CRC). How often should Signatera be ordered for CRC patients?

Signatera and Altera Insurance Coverage and Billing

The first personalized ctDNA test to identify molecular residual disease and optimize treatment decisions.

Signatera Discussion Guide

Signatera is a new custom-built test that uses tumor and blood samples to detect very low levels of molecular residual disease (MRD), or small traces of cancer.

Tissue Sample Collection Instructions

Overview document on how Signatera collections a FFPE sample.

Recommended blood draw and testing frequency

Overview document detailing blood draw and testing frequency.

Tumor Genomic Profile

Altera offers a whole exome and transcriptome-based approach for Comprehensive Genomic Profiling (CGP) with boosted >500X coverage for 440 medically important genes.